- Home
- GRX vs VSTM Comparison
GRX vs VSTM Comparison
Compare GRX & VSTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRX
- VSTM
- Stock Information
- Founded
- GRX 2007
- VSTM 2010
- Country
- GRX United States
- VSTM United States
- Employees
- GRX N/A
- VSTM N/A
- Industry
- GRX Finance/Investors Services
- VSTM Biotechnology: Pharmaceutical Preparations
- Sector
- GRX Finance
- VSTM Health Care
- Exchange
- GRX Nasdaq
- VSTM Nasdaq
- Market Cap
- GRX 159.6M
- VSTM 132.0M
- IPO Year
- GRX N/A
- VSTM 2012
- Fundamental
- Price
- GRX $10.10
- VSTM $3.93
- Analyst Decision
- GRX
- VSTM Strong Buy
- Analyst Count
- GRX 0
- VSTM 8
- Target Price
- GRX N/A
- VSTM $14.57
- AVG Volume (30 Days)
- GRX 39.7K
- VSTM 944.1K
- Earning Date
- GRX 01-01-0001
- VSTM 11-06-2024
- Dividend Yield
- GRX 5.98%
- VSTM N/A
- EPS Growth
- GRX N/A
- VSTM N/A
- EPS
- GRX 0.26
- VSTM N/A
- Revenue
- GRX N/A
- VSTM $10,000,000.00
- Revenue This Year
- GRX N/A
- VSTM N/A
- Revenue Next Year
- GRX N/A
- VSTM $108.05
- P/E Ratio
- GRX $38.50
- VSTM N/A
- Revenue Growth
- GRX N/A
- VSTM N/A
- 52 Week Low
- GRX $7.73
- VSTM $2.10
- 52 Week High
- GRX $10.40
- VSTM $14.22
- Technical
- Relative Strength Index (RSI)
- GRX 34.24
- VSTM 54.97
- Support Level
- GRX $10.06
- VSTM $3.71
- Resistance Level
- GRX $10.26
- VSTM $4.29
- Average True Range (ATR)
- GRX 0.15
- VSTM 0.36
- MACD
- GRX -0.02
- VSTM -0.05
- Stochastic Oscillator
- GRX 13.24
- VSTM 34.09
About GRX The Gabelli Healthcare & Wellness Trust of Beneficial Interest
Gabelli Healthcare & WellnessRx Trust operates as a diversified closed-end management investment company. The investment objective of the fund is the long-term growth of capital. The fund invests at least its assets in equity securities and income-producing securities of domestic and foreign companies in the healthcare and wellness industries. It invests in various sectors, of which Health Care Providers & Services, Food, Health Care Equipment and Supplies, and Pharmaceuticals account for the majority of the weightage.
About VSTM Verastem Inc.
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.